Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

Al Kaabi Nawal; Zhang Yuntao; Xia Shengli; Yang Yunkai; Al Qahtani Manaf M.; Abdulrazzaq Najiba; Al Nusair Majed; Hassany Mohamed; Jawad Jaleela S.; Abdalla Jehad; Hussein Salah Eldin; Al Mazrouei Shamma K.; Al Karam Maysoon; Li Xinguo; Yang Xuqin; Wang Wei; Lai Bonan; Chen Wei; Huang Shihe; Wang Qian; Yang Tian; Liu Yang; Ma Rui; Hussain Zaidoon M.; Khan Tehmina; Saifuddin Fasihuddin Mohammed; You Wangyang; Xie Zhiqiang; Zhao Yuxiu; Jiang Zhiwei; Zhao Guoqing; Zhang Yanbo; Mahmoud Sally; ElTantawy Islam; Xiao Peng; Koshy Ashish; Zaher Walid Abbas; Wang Hui; Duan Kai; Pan An; Yang Xiaoming

首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

【24h】

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

机译：2次灭活SARS-COV-2疫苗对成人症状Covid-19感染的影响A型临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This interim analysis of an ongoing randomized trial evaluates the efficacy of 2 inactivated coronavirus vaccines for preventing symptomatic COVID-19 in healthy adults and adverse events after immunization.

机译：2019冠状病毒疾病的临床分析结果表明，2种灭活冠状病毒疫苗能有效预防健康成人的COVID-19症状和免疫不良反应。

著录项

来源
《JAMA: the Journal of the American Medical Association》 |2021年第1期|共11页
作者
Al Kaabi Nawal; Zhang Yuntao; Xia Shengli; Yang Yunkai; Al Qahtani Manaf M.; Abdulrazzaq Najiba; Al Nusair Majed; Hassany Mohamed; Jawad Jaleela S.; Abdalla Jehad; Hussein Salah Eldin; Al Mazrouei Shamma K.; Al Karam Maysoon; Li Xinguo; Yang Xuqin; Wang Wei; Lai Bonan; Chen Wei; Huang Shihe; Wang Qian; Yang Tian; Liu Yang; Ma Rui; Hussain Zaidoon M.; Khan Tehmina; Saifuddin Fasihuddin Mohammed; You Wangyang; Xie Zhiqiang; Zhao Yuxiu; Jiang Zhiwei; Zhao Guoqing; Zhang Yanbo; Mahmoud Sally; ElTantawy Islam; Xiao Peng; Koshy Ashish; Zaher Walid Abbas; Wang Hui; Duan Kai; Pan An; Yang Xiaoming;
展开▼
作者单位

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

Henan Prov Ctr Dis Control &

Prevent Zhengzhou Henan Peoples R China;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

Mil Hosp Bahrain Def Force Royal Med Serv Riffa Bahrain;

Minist Hlth &

Prevent Abu Dhabi U Arab Emirates;

Prince Hamza Hosp Amman Jordan;

Minist Hlth Cairo Cairo Egypt;

Minist Hlth Sanabis Bahrain;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Wuhan Inst Biol Prod Co Ltd Natl Engn Technol Res Ctr Combined Vaccines Wuhan Hubei Peoples R;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

Beijing Inst Biol Prod Co Ltd Beijing Peoples R China;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

Wuhan Inst Biol Prod Co Ltd Natl Engn Technol Res Ctr Combined Vaccines Wuhan Hubei Peoples R;

Wuhan Inst Biol Prod Co Ltd Natl Engn Technol Res Ctr Combined Vaccines Wuhan Hubei Peoples R;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

Beijing Inst Biol Prod Co Ltd Beijing Peoples R China;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Abu Dhabi Hlth Serv Co SEHA Sheikh Khalifa Med City Abu Dhabi U Arab Emirates;

Henan Prov Ctr Dis Control &

Prevent Zhengzhou Henan Peoples R China;

Henan Prov Ctr Dis Control &

Prevent Zhengzhou Henan Peoples R China;

Beijing Inst Biol Prod Co Ltd Beijing Peoples R China;

Beijing Key Tech Stat Consulting Co Ltd Beijing Peoples R China;

Beijing Key Tech Stat Consulting Co Ltd Beijing Peoples R China;

Huazhong Univ Sci &

Technol Tongji Med Coll Dept Epidemiol &

Biostat Minist Educ Key Lab;

G42 Healthcare Abu Dhabi U Arab Emirates;

G42 Healthcare Abu Dhabi U Arab Emirates;

G42 Healthcare Abu Dhabi U Arab Emirates;

Huazhong Univ Sci &

Technol Tongji Med Coll Dept Epidemiol &

Biostat Minist Educ Key Lab;

G42 Healthcare Abu Dhabi U Arab Emirates;

Beijing Inst Biol Prod Co Ltd Beijing Peoples R China;

Wuhan Inst Biol Prod Co Ltd Natl Engn Technol Res Ctr Combined Vaccines Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Dept Epidemiol &

Biostat Minist Educ Key Lab;

China Natl Biotec Grp Co Ltd B2 Shuangqiao Rd Beijing Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
入库时间 2022-08-20 20:47:14

相似文献

外文文献
中文文献
专利

1. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults:randomized,double-blind,and placebo-controlled phase 1 and phase 2 clinical trials [J] . Hong-Xing Pan, Jing-Xin Li, Dan-Dan Zhu, 中华医学杂志（英文版） . 2021,第011期
2. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial [J] . Morteza Shakhsi Niaee, Yazdan Naderi, Fatemeh Amini, 亚太热带医药杂志（英文版） . 2021,第006期
3. Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates [J] . Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, 中国病毒学：英文版 . 2021,第005期
4. Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase 2162; randomized clinical trial in adults [J] . Song Joon Young, Lee Jacob, Woo Heung Jeong, Human vaccines & immunotherapeutics. . 2019,第3期

机译：卵子灭活的四价流感疫苗（GC3110A）的免疫原性和安全性与具有交替B株的两种灭活三价流感疫苗：2162阶段; 随机化的成人临床试验
5. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18?59 years: A phase I randomized, double-blinded, controlled trial [J] . Pu Jing, Yu Qin, Yin Zhifang, Vaccine . 2021,第20期

机译：在18岁的中国成人中灭活的SARS-COV-2疫苗的安全性和免疫原性，59岁：一期随机化，双盲，受控试验
6. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial [J] . Wu Zhiwei, Hu Yaling, Xu Miao, The Lancet infectious diseases . 2021,第6期

机译：60岁及以上的健康成人中灭活的SARS-COV-2疫苗（Coronavac）的安全性，耐受性和免疫原性：随机，双盲，安慰剂控制，第1/2期临床试验
7. A-share Stock Reactions to the Approval of COVID-19 Vaccine Clinical Trial: An Event Study Model of Listed Pharmaceutical Firms’ Returns [C] . Xiong Kewei, Liang Yuanyuan International Conference on Economic Management and Model Engineering . 2020

机译：A股股票反应对Covid-19疫苗临床试验的批准：列出的制药公司回报的事件研究模式
8. Educational intervention in adult asthma: A randomized clinical trial to determine if adult with asthma can learn how to use a Metered Dose Inhaler (MDI). [D] . Acosta, Juan. 2009

机译：成人哮喘的教育干预：一项随机临床试验，用于确定成人哮喘是否可以学习如何使用计量吸入器（MDI）。
9. Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults [O] . Joon Young Song, Jacob Lee, Heung Jeong Woo, 2019

机译：鸡蛋基灭活四价流感疫苗（GC3110A）与两种灭活B株两种灭活三价流感疫苗的免疫原性和安全性：成人的一项Ⅲ期随机临床试验
10. Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial [O] . Yanjun Zhang, Gang Zeng, Hongxing Pan, 2020

机译：28-59岁的健康成人中SARS-COV-2灭活疫苗的免疫原性和安全性：随机，双盲和安慰剂控制第2期临床试验报告
11. Prospective Randomized Clinical Trial of Celecoxib for the Control of Symptomatic Plexiform Neurofibroma in Neurofibromatosis 1 [R] . Gusella, J. F. , Plotkin, S. 2005

机译：塞来昔布用于控制神经纤维瘤病中症状性丛状神经纤维瘤的前瞻性随机临床试验1

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅